Evidence map›Paper›PMID 27543412›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2017

Clinical Impact and Provider Acceptability of Real-Time Antimicrobial Stewardship Decision Support for Rapid Diagnostics in Children With Positive Blood Culture Results.

Kevin Messacar, Amanda L Hurst, Jason Child, Kristen Campbell, Claire Palmer, Stacey Hamilton, Elaine Dowell, Christine C Robinson, Sarah K Parker, Samuel R Dominguez

Abstract read
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Antimicrobial and diagnostic stewardship: opportunities for return on investment.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Article
  6. Observational
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. The impact of the BIOFIREEuropean journal of pediatrics · 2024
    Article
  13. Article
  14. Blood culture identification (BCID) performance in polymicrobial bacteremia.Diagnostic microbiology and infectious disease · 2023
    Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kevin MessacarDepartment of Pediatrics, Section of Infectious Diseases.
Amanda L HurstPharmacy.
Jason ChildPharmacy.
Kristen CampbellDepartment of Biostatistics and Informatics, University of Colorado School of Public Health.
Claire PalmerDepartment of Pediatrics, University of Colorado.
Stacey HamiltonDepartment of Pathology and Laboratory Medicine.
Elaine DowellDepartment of Pathology and Laboratory Medicine.
Christine C RobinsonDepartment of Pathology and Laboratory Medicine.
Sarah K ParkerDepartment of Pediatrics, Section of Infectious Diseases.
Samuel R DominguezDepartment of Pediatrics, Section of Infectious Diseases.

Funding

Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
NCATS NIH HHS UL1 TR000154
6 · The paper itself

Abstract

backgroundRapid diagnostic technologies for infectious diseases have the potential to improve clinical outcomes, but guideline-recommended antimicrobial stewardship (AS) strategies are not currently optimized for rapid intervention. We evaluated the clinical impact and provider acceptability of implementing real-time AS decision support for children with positive blood culture results according to the FilmArray blood culture identification panel (BCID [BioFire Diagnostics]) at Children's Hospital Colorado.

methodsA pre-post quasi-experimental design was used to compare the outcomes of 100 postintervention children with positive blood culture results matched with 200 preintervention control children. Causative organisms in the preintervention group were identified using conventional microbiologic techniques and communicated to providers by a microbiology technologist. Postintervention organisms were identified by the BCID and communicated by an AS provider in real time with interpretation and antimicrobial recommendations. The primary outcome was time to optimal antimicrobial therapy (time from blood culture collection to start of predetermined pathogen-specific regimen or antimicrobial discontinuation for contaminants) compared by a log-rank test and Kaplan-Meier analysis. Provider acceptability of the intervention was assessed via E-mailed surveys.

resultsThe median time to optimal therapy decreased from 60.2 hours before intervention to 26.7 hours after intervention (P = .001). Among children with blood cultures that contained true pathogens, the time to effective antimicrobial therapy decreased from 6.9 to 3.4 hours (P = .03). Unnecessary antibiotic initiation for children with a culture that contained organisms considered to be contaminants decreased from 76% to 26% (P < .001). Providers reported a change in management as a result of BCID results in 73% of the cases and a mean overall satisfaction rating of 4.8 on a 5-point Likert scale.

conclusionsReal-time AS decision support for rapid diagnostics is associated with improved antimicrobial use and high satisfaction ratings by providers.

Indexed as

Antimicrobial StewardshipAttitude of Health PersonnelAnti-Infective AgentsChildChild, PreschoolCommunicable DiseasesControlled Before-After StudiesFemaleHumansInfantMaleTreatment OutcomeAnti-Infective Agentsantimicrobial stewardshipbloodstream infectionsoutcomesrapid diagnostics

Identifiers

PMID27543412
PMCPMC5907879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.